MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

29 Oct 2024 Evaluate
A slight decline in the revenue of Rs. 323.32 millions was seen for the September 2024 quarter as against Rs. 334.15 millions during year-ago period.Net profit declined -2.12% to Rs. 64.16 millions from Rs. 65.55 millions.Operating Profit saw a handsome growth to 114.98 millions from 100.30 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 323.32 334.15 -3.24 571.12 602.50 -5.21 1258.95 913.58 37.80
Other Income 1.88 8.05 -76.65 7.33 11.25 -34.84 30.67 7.17 327.75
PBIDT 114.98 100.30 14.64 201.67 172.62 16.83 448.77 241.60 85.75
Interest 4.28 0.12 3466.67 7.44 0.46 1517.39 5.98 1.80 232.22
PBDT 110.70 100.18 10.50 194.23 172.16 12.82 442.79 239.80 84.65
Depreciation 24.24 14.09 72.04 44.42 24.20 83.55 61.10 37.42 63.28
PBT 86.46 86.09 0.43 149.81 147.96 1.25 381.69 202.38 88.60
TAX 22.30 20.54 8.57 39.13 37.01 5.73 100.52 50.53 98.93
Deferred Tax -0.14 0.70 -120.00 0.14 0.89 -84.27 6.74 -2.84 -337.32
PAT 64.16 65.55 -2.12 110.68 110.95 -0.24 281.17 151.85 85.16
Equity 128.43 123.09 4.34 128.43 125.69 2.18 125.83 121.07 3.93
PBIDTM(%) 35.56 30.02 18.48 35.31 28.65 23.25 35.65 26.45 34.79
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..